Product Information
AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK) is a brand product labeled by Biogen Inc., priced at $8776.2523 per EA under NDC 59627022205. Its NADAC has been published 594 times since May 20, 2015.
Manufacturer
Biogen Inc.NDC
59627022205
Classification
Brand
Dosage Form
KIT
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Approval Type
Biologic (BLA)
FDA Application
BLA103628On Market Since
8/29/2014
Price Statistics
The NADAC for AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK) has been published 594 times since May 20, 2015, and over the history we have for it it has risen 81.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8776.2523 per EA |
|---|---|
| All-time high | $8821.4088 (Jul 15, 2026) |
| All-time low | $4849.5883 (May 20, 2015) |
| 52-week high | $8821.4088 |
| 52-week low | $8383.7660 |
| Median price | $7025.4074 |
| Average price | $7016.7425 |
| Largest weekly change | +8.0% (Jan 11, 2017) |
| Weeks tracked | 594 |
| Tracking since | May 20, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biogen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
interferon beta-1a market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK)?
The current National Average Drug Acquisition Cost (NADAC) for AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK), manufactured by Biogen Inc., is $8776.2523 per EA (NDC 59627022205), effective Sep 30, 2026.
How has the price of AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK) changed over time?
Over the history we have for it, the NADAC for AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK) has risen 81.0%. It has been tracked across 594 weekly CMS publications since May 20, 2015.
What are the highest and lowest recorded NADAC prices for AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK)?
Since May 20, 2015, the NADAC for AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK) has ranged from a low of $4849.5883 (May 20, 2015) to a high of $8821.4088 (Jul 15, 2026), with a median of $7025.4074 per EA.
Are there cheaper alternatives to AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK)?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AVONEX PEN 30 MCG/0.5 ML KIT (4 PACK), is $8772.0250 per EA — about 0% below AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK).
Who manufactures AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK)?
AVONEX 30 MCG/0.5 ML SYRINGE KIT (4 PACK) (NDC 59627022205) is labeled by Biogen Inc., and CMS classifies it as a brand product.